Cargando…
Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic Nephropathy
INTRODUCTION: Metformin use in advanced chronic kidney disease is controversial. This study sought to examine the pharmacokinetics, safety, and efficacy of low-dose metformin in patients with type 2 diabetes and stage 4 chronic kidney disease. METHODS: In this open-label, phase I trial, 3 consecutiv...
Autores principales: | Dissanayake, Ajith Munasinghe, Wheldon, Mark Christopher, Ahmed, Jafar, Hood, Christopher John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720630/ https://www.ncbi.nlm.nih.gov/pubmed/29318219 http://dx.doi.org/10.1016/j.ekir.2017.03.005 |
Ejemplares similares
-
Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin‐naïve type 2 diabetes
por: Dissanayake, Ajith M., et al.
Publicado: (2018) -
Lisfranc fracture-dislocation precipitating acute Charcot arthopathy in a neuropathic diabetic foot: a case report
por: Yeoh, Joey, et al.
Publicado: (2008) -
Gallic acid improves the metformin effects on diabetic kidney disease in mice
por: Hong, Yan, et al.
Publicado: (2023) -
Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy
por: Wang, Fengzhen, et al.
Publicado: (2021) -
Comprehensive Lipidome Profiling of the Kidney in Early-Stage Diabetic Nephropathy
por: Hou, Biyu, et al.
Publicado: (2020)